CagriSema: Semaglutide Plus a Second Fullness Signal
CagriSema combines semaglutide with cagrilintide, an amylin analogue targeting a separate fullness pathway. Learn how it...
How GLP-1 works in the body β the hormone science behind appetite, blood sugar and modern weight-loss medicine.
CagriSema combines semaglutide with cagrilintide, an amylin analogue targeting a separate fullness pathway. Learn how it...
Survodutide is a GLP-1 and glucagon dual agonist from Boehringer Ingelheim. Learn its phase 3 SYNCHRONIZE results, how i...
Mazdutide was approved in China in June 2025 for weight management. Learn how this GLP-1 and glucagon dual agonist works...
Single, dual and triple agonists explained. Learn what GLP-1, GIP, glucagon and amylin each do, and why stacking recepto...
Sublingual delivery uses the thin, vascular tissue under your tongue to absorb compounds directly into the bloodstream....
Sublingual drops and injections deliver GLP-1 pathway support through different routes. Here is what changes with delive...
GLP-1 receptor agonists are drugs that mimic the fullness hormone GLP-1. Ozempic, Wegovy, and Mounjaro are all in this c...
GLP-1 (glucagon-like peptide-1) is the gut hormone that signals fullness after eating. Here is what it does, where it co...
GLP-1 reduces hunger by activating specific neurons in the hypothalamus. Here is exactly how the brain receives and acts...